Drug ‘Aromasin’ prevents breast cancer
In what may be seen as a positive development, it has emerged that the anti-estrogen drug Aromasin reduces the risk of breast cancer recurrence by about one-third in postmenopausal women previously treated with tamoxifen.
According to researchers, `Aromasin`, which has been approved by the FDA, obstructs the production of estrogen that is made outside of the ovaries.
The drug is also believed to prevent malignancies in women who have a risk due to age, family history and abnormal biopsy results.
Researchers claim that Aromasin reduces the risk of invasive breast cancer by 65% compared to a placebo.
Two other drugs, tamoxifen and raloxifene have also been approved by the FDA for cancer prevention though they have side effects like blood clots, strokes, leg cramps and joint pain.
More from India
More from World
More from Sports
More from Entertaiment
- Vyapam Scam: IMA president Sudhir Tiwari fears life threat
- Vyapam Scam: Mystery over journalist Akshay Singh's death continues
- Jhansi police launches ‘Citizen Cop’ android app
- Panel discussion on RSS's 'Muslim Rashtriya Manch' first Iftaar party
- Kailash Vijayvargiya on Akshay Singh's death: Is a journalist bigger than me?
- Vyapam scam: MP medical college dean found dead in hotel, body sent for post-mortem
- Vyapam scam: Last rites of journalist Akshay Singh performed; MP CM assures of SIT probe
- Photographer captures International Space Station flying across moon
- PM Narendra Modi holds talks with Uzbek leader
- 'Selfie with daughter' controversy: Bollywood supports Shruti Seth